A regulator of ubiquitin-proteasome activity, 2-hexyldecanol, suppresses melanin synthesis and the appearance of facial hyperpigmented spots

British Journal of Dermatology

Volumn 169, Issue SUPPL.2, 2013, Pages 39-44

  Hakozaki, T ^a   Laughlin, T ^a   Zhao, S ^a   Wang, J ^a   Deng, D ^b   Jewell Motz, E ^a   Elstun, L ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b P and G Technology (Beijing) Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 HEXYLDECANOL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DECANOL; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHINESE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXPLANT; FACE; FEMALE; HUMAN; HUMAN CELL; HYPERPIGMENTATION; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANIMALS; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DOUBLE-BLIND METHOD; FATTY ALCOHOLS; FEMALE; HUMANS; HYPERPIGMENTATION; LEUPEPTINS; MELANINS; MELANOCYTES; MICE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UP-REGULATION;

EID: 84879357806     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12364     Document Type: Article

References (22)

1. Hakozaki T, Swanson CL, Bissett DL,. Hyperpigmentation in aging skin. In: Textbook of Aging Skin (, Farage MA, Miller KW, Maibach HI, eds), Berlin: Springer, 2010; 495-502.
2. Chi A, Valencia JC, Hu Z-Z, et al,. Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res 2006; 5: 3135-44.
3. Boissy RE,. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol 2003; 12 (Suppl. 2): 5-12.
4. Bellei B, Maresca V, Flori E, et al,. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem 2010; 285: 7288-99.
5. Ando H, Ichihashi M, Hearing VJ,. Role of the ubiquitin proteasome system in regulating skin pigmentation. Int J Mol Sci 2009; 10: 4428-34.
6. Watabe H, Valencia JC, Yasumoto K, et al,. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J Biol Chem 2004; 279: 7971-81.
7. Atrux-Tallau N, Huynh NTT, Gardette L, et al,. Effects of physical and chemical treatments upon biophysical properties and micro-relief of human skin. Arch Dermatol Res 2008; 300: 243-51.
8. Lee DH, Goldbery AL,. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8: 397-403.
9. Stein RL, Melandri F, Dick L,. Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry 1996; 35: 3899-908.
10. Bissett DL, Robinson LR, Raleigh PS, et al,. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-Lphenylalanine and its combination with niacinamide. J Cosmet Dermatol 2009; 8: 260-6.
11. Miyamoto K, Takiwaki H, Hillebrand GG, Arase S,. Development of a digital imaging system for objective measurement of hyperpigmented spots on the face. Skin Res Technol 2002; 8: 227-35.
12. Huang L, Ho P, Chen CH,. Activation and inhibition of proteasomes by betulinic acid and its derivatives. FEBS Lett 2007; 581: 4955-9.
13. Jeong HJ, Chai HB, Park SY, et al,. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Bioorg Med Chem Lett 1999; 9: 1201-4.
14. Pickart CM,. Targeting of substrates to the 26S proteasome. FASEB J 1997; 11: 1055-66.
15. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol 1999; 13: 1686-94.
16. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ,. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes. Cancer Res 2000; 60: 2247-52.
17. Kageyama A, Oka M, Okada T, et al,. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase. J Biol Chem 2004; 279: 27774-80.
18. Seiberg M, Paine C, Sharlow E, et al,. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000; 254: 25-32.
19. Hakozaki T, Minwalla L, Zhuang J, et al,. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20-31.
20. Nannan C, Seiberg M, Lin CB,. Cathepsin L2 levels inversely correlate with skin color. J Invest Dermatol 2006; 126: 2345-7.
21. Mammone T, Marenus K, Juizzuddin N, et al,. Evidence and utility of melanin degrading enzymes. J Cosmet Sci 2003; 55: 116-17.
22. Ebanks JP, Koshoffer A, Wickett RR, et al,. Epidermal keratinocytes from light vs. dark skin exhibit differential degradation of melanosomes. J Invest Dermatol 2011; 131: 1226-33.